Anti-drug antibodies to antibody-based therapeutics in multiple sclerosis
{{output}}
Multiple sclerosis is the major demyelinating autoimmune disease of the central nervous system. Relapsing MS can be treated by a number of approved monoclonal antibodies that currently target: CD20, CD25 (withdrawn), CD49d and CD52. These all target potentiall... ...
